𝔖 Bobbio Scriptorium
✦   LIBER   ✦

A phase II trial of deoxyspergualin in recurrent squamous cell head and neck cancer

✍ Scribed by David G. Pfister; Dean Bajorin; Robert J. Motzer; Howard Scher; Carl Louison; Louis Harrison; Jatin Shah; Elliot Strong; George Bosl

Publisher
Springer US
Year
1993
Tongue
English
Weight
269 KB
Volume
11
Category
Article
ISSN
0167-6997

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Phase II trial of mitoxantrone in head a
Phase II trial of mitoxantrone in head and neck cancer
✍ Matti S. Aapro; Davis S. Alberts πŸ“‚ Article πŸ“… 1984 πŸ› Springer US 🌐 English βš– 136 KB

Mitoxantrone (l,4-dihydroxy-5,8-bis((2-[(2-hydroxyethyl)amino]ethyl)amino)-9, 10 anthracenedione dihydrochloride, NSC 301,739) is a new aminoanthraquinone derivative with clinical activity in the treatment of advanced breast cancer (1, 2), lymphoma (3), and acute leukemia (4). We have carried out a

A phase II trial of cisplatin and vinore
A phase II trial of cisplatin and vinorelbine in patients with recurrent or metastatic squamous cell carcinoma of the head and neck
✍ Enrique Espinosa; Pilar Zamora; Alfredo MillΓ‘; Serafin Morales; Raquel Molina; M πŸ“‚ Article πŸ“… 2002 πŸ› John Wiley and Sons 🌐 English βš– 75 KB πŸ‘ 2 views

## Abstract ## Objective. We assessed the response rate and the toxicity of cisplatin plus vinorelbine in patients with this condition. ## Patients and Method. Forty‐two patients were included. Therapy consisted of cisplatin, 100 mg/m^2^ on day 1, and vinorelbine, 25 mg/m^2^ on days 1 and 8, giv

A phase II study of mitoxantrone in adva
A phase II study of mitoxantrone in advanced squamous cell cancer of the head and neck
✍ H. Wheeler; R. L. Woods; J. Page; J. Levi πŸ“‚ Article πŸ“… 1990 πŸ› Springer US 🌐 English βš– 186 KB

Twenty patients with advanced squamous cell carcinomas (SCC) of the head and neck were entered into a phase II study of mitoxantrone at a dosage of either 12 mg/m2 or 14 mg/m2 given at 3 weekly intervals. None of the patients had received prior chemotherapy. One patient had a partial remission. Two